84% of Olongapo's target population vaxxed with 1st dose of COVID jab | Inquirer News

84% of Olongapo’s target population vaxxed with 1st dose of COVID jab

/ 07:50 PM December 14, 2021

The government of Olongapo City continues to roll out of COVID-19 vaccination as it inches closer to achieving herd immunity against the viral disease. (Photo courtesy of Olongapo City Information Center)

OLONGAPO CITY — At least 152,693 residents or 84 percent of the target population had been inoculated with the first dose of the vaccine against COVID-19, local data showed on Monday, December 13

According to the city health office, the local government had already administered 258,600 COVID-19 shots since it started the rollout in the middle of this year.

ADVERTISEMENT

Of this figure, 113, 735 residents or 58 percent had been fully vaccinated, including those who received the single-shot Janssen vaccine.

FEATURED STORIES

At least 1, 221 more residents belonging to the medical frontliners had received the booster shot.

The city is targeting 182,000 residents or 70 percent of its 260,000-population to achieve herd immunity against the viral disease.

As of Monday, the city’s active cases stood at five with no new infections recorded in the last few days.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Olongapo, vaccine

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.